Medical Expulsive Therapy: Is It Time to SUSPEND Judgement? Tarik AmerGareth JonesOmar Aboumarzouk Current Opinion 29 March 2017 Pages: 809 - 812
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer Saoirse O. DollyDearbhaile C. CollinsTimothy A. Yap Current Opinion 04 April 2017 Pages: 813 - 827
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management Alicia SantosEugenia ResminiSusan M. Webb Therapy in Practice 10 April 2017 Pages: 829 - 842
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies Jonathan MoreiraAlexander TobiasMark Agulnik Review Article 05 April 2017 Pages: 843 - 857
Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions Marie LundTonny Studsgaard PetersenKim Peder Dalhoff Review Article 05 April 2017 Pages: 859 - 883
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis A. NandoskarJ. RaffelR. S. Nicholas Review Article 20 April 2017 Pages: 885 - 910
Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4 Zaina T. Al-SalamaEmma D. Deeks Adis Drug Evaluation 17 April 2017 Pages: 911 - 921
Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects Shubhasree BanerjeeAnn BiehlDaniella M. Schwartz Erratum 01 April 2017 Pages: 939 - 939